TD Asset Management »

Catalyst Pharmaceutical Partners shares owned by TD Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 72k 19.56
2024-06-30 $254k 16k 15.49

More positions owned by TD Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Canadian Pacific Kansas City (CP)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Broadcom (AVGO)
Canadian Natural Resources (CNQ)
Cibc Cad (CM)
UnitedHealth (UNH)

View all positions for TD Asset Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Royce & Associates
Goldman Sachs Group
Northern Trust
Robeco Investment Management
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners